Tag: conflict of interest and medical journals
Medical Ghostwriting: When an “Author” Is Not Necessarily an “Author”
Ghostwriting, which is prominent in the psychiatry literature, is a scam in which pharmaceutical companies use an academic sleight of hand to stump the naïve reader. It is time for editors of the major medical journals to use the same standards of authorship found in the humanities and social sciences.
Helping People Come Off Medication—Bad for Business?
The message in journal editorials, comments and opinion articles, is that 'this new study shows great promise' and that 'we need further research'. My interpretation is: 'give us the money and we will be happy to carry this out'. With the implied promise that, once this new research has been done, we will get a better world. Sadly this is rarely ever the case.
Studies Often Fall Short on Conflict-of-Interest Disclosures
From Kaiser Health News: "Papers in medical journals go through rigorous peer review and meticulous data analysis. Yet many of these articles are missing a...
This is the Sickening Amount Pharmaceutical Companies Pay Top Journal Editors
From Science Alert: "It's no secret that scientists can be corrupted — in the past, researchers have purposefully hidden data on climate change, and the...
Interview: Researchers Deconstruct Ghostwritten Industry Trial for Antidepressant
Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.